Genetic factors in cardiac hypertrophy
- PMID: 15201163
- DOI: 10.1196/annals.1302.019
Genetic factors in cardiac hypertrophy
Abstract
Cardiac hypertrophy is an adaptive response to any cardiac insult or stress that increases hemodynamic load. Cardiac hypertrophy can exist in a state of compensation or progress to a decompensated state (i.e., heart failure) over time. It has been established through transgenic overexpression and gene ablation studies that multiple signaling pathways are involved in the induction of hypertrophy as well as its decompensation. This article reviews the role of G alpha q in the development of pressure overload hypertrophy and discusses the relationships between G alpha q and beta-adrenergic receptors, RGS proteins, and the proapoptotic factor, Nix/Bnip3L.
Similar articles
-
G-proteins in growth and apoptosis: lessons from the heart.Oncogene. 2001 Mar 26;20(13):1626-34. doi: 10.1038/sj.onc.1204275. Oncogene. 2001. PMID: 11313910 Review.
-
Absence of pressure overload induced myocardial hypertrophy after conditional inactivation of Galphaq/Galpha11 in cardiomyocytes.Nat Med. 2001 Nov;7(11):1236-40. doi: 10.1038/nm1101-1236. Nat Med. 2001. PMID: 11689889
-
Cardiac-specific overexpression of diacylglycerol kinase zeta prevents Gq protein-coupled receptor agonist-induced cardiac hypertrophy in transgenic mice.Circulation. 2006 Jan 3;113(1):60-6. doi: 10.1161/CIRCULATIONAHA.105.560771. Epub 2005 Dec 27. Circulation. 2006. PMID: 16380548
-
Still stressed out but doing fine: normalization of wall stress is superfluous to maintaining cardiac function in chronic pressure overload.Circulation. 2002 Jan 1;105(1):8-10. Circulation. 2002. PMID: 11772868 No abstract available.
-
Signaling pathways for cardiac hypertrophy and failure.N Engl J Med. 1999 Oct 21;341(17):1276-83. doi: 10.1056/NEJM199910213411706. N Engl J Med. 1999. PMID: 10528039 Review. No abstract available.
Cited by
-
RhoGEF12 controls cardiac remodeling by integrating G protein- and integrin-dependent signaling cascades.J Exp Med. 2013 Apr 8;210(4):665-73. doi: 10.1084/jem.20122126. Epub 2013 Mar 25. J Exp Med. 2013. PMID: 23530122 Free PMC article.
-
Kruppel-like factor 15 is a regulator of cardiomyocyte hypertrophy.Proc Natl Acad Sci U S A. 2007 Apr 24;104(17):7074-9. doi: 10.1073/pnas.0701981104. Epub 2007 Apr 16. Proc Natl Acad Sci U S A. 2007. PMID: 17438289 Free PMC article.
-
Deregulation of RGS2 in cardiovascular diseases.Front Biosci (Schol Ed). 2010 Jan 1;2(2):547-57. doi: 10.2741/s84. Front Biosci (Schol Ed). 2010. PMID: 20036967 Free PMC article. Review.
-
miRNA regulation during cardiac development and remodeling in cardiomyopathy.EXCLI J. 2013 Nov 26;12:980-92. eCollection 2013. EXCLI J. 2013. PMID: 27092038 Free PMC article. Review.
-
MicroRNAs are aberrantly expressed in hypertrophic heart: do they play a role in cardiac hypertrophy?Am J Pathol. 2007 Jun;170(6):1831-40. doi: 10.2353/ajpath.2007.061170. Am J Pathol. 2007. PMID: 17525252 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources